Patents
Patents for C07D 231 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings (25,550)
12/2005
12/12/2005WO2005121110A1 Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
12/08/2005WO2005116027A2 Indazole and indolone derivatives and their use as pharmaceuticals
12/08/2005WO2005115992A1 Theramutein modulators
12/08/2005WO2005115991A1 Anti-cytokine heterocyclic compounds
12/08/2005WO2005115989A1 Method for producing 1,5-diphenylpyrazole carboxylic acid derivatives
12/08/2005WO2005082860A8 Tetracyclines and their use as calpain inhibitors
12/08/2005WO2005009951A3 Diphenyl substituted cycloalkanes, compositions containing such compounds and methods of use
12/08/2005WO2004098589A8 4- bromo - 5 - (2- chloro - benzoylamino) - 1h - pyrazole - 3 - carboxylic acid amide derivatives and related compounds as bradykinin b1 receptor antagonists for the treatment of inflammatory diseases
12/08/2005WO2004093805A3 Selective spirocyclic glucocorticoid receptor modulators
12/08/2005US20050272931 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272823 improved selectivity and pharmacokinetic properties; 6-Fluoro-1-[(1 H-indazol-4-yl)amino]-4,4-dimethyl-2-(trifluoromethyl)-1,2,3,4-tetrahydronaphthalene-2,5-diol; cyclization of imines
12/08/2005US20050272794 Pyrazole derivatives, compositions containing such compounds and methods of use
12/08/2005US20050272793 Pyrazole compounds and uses related thereto
12/08/2005US20050272786 Naphthyl benzoxazoles and benzisoxazoles as estrogenic agents
12/08/2005US20050272784 Inhibitors of bacterial Type III protein secretion systems
12/08/2005US20050272777 Vanilloid receptor ligands and their use in treatments
12/08/2005US20050272745 Novel piperidine and piperazine derivatives
12/08/2005US20050272727 As antitumor and anticancer agents
12/08/2005US20050272709 tert-butyl-[5-methyl-4-(phenylhydrazono)-4H-pyrazol-3-yl]amine; 4-(3-fluorophenylhydrazono)-5-methyl-2H-pyrazol-3-ylamine; demonstrate anti-proliferative activity, and may promote apoptosis in cells lacking normal regulation of cell cycle and death
12/08/2005US20050272699 1- and 2-substituted with carbo- or heterocyclic groups, e.g., 3-[4-(5-Difluoromethoxy-3-trifluoromethyl-pyrazol-1-yl)-phenyl]-2-(2-fluoro-phenyl)-acrylonitrile; inhibit the production of IL-2.
12/08/2005US20050271584 Biphenyls and fluorenes as imaging agents in alzheimer's disease
12/08/2005DE102004023122A1 Kationische Farbstoffe und diese Verbindungen enthaltende Färbemittel für Keratinfasern Cationic dyes and colorants comprising these compounds for keratin fibers
12/08/2005CA2568050A1 Indazole and indolone derivatives and their use as pharmaceuticals
12/08/2005CA2567813A1 Theramutein modulators
12/08/2005CA2563466A1 Anti-cytokine heterocyclic compounds
12/08/2005CA2557284A1 Method for producing 1,5-diphenylpyrazole carboxylic acid derivatives
12/07/2005EP1602658A1 Tricyclic pyrazole derivatives as cannabinoid receptor antagonists
12/07/2005EP1602642A1 Imino ether derivative compounds and drugs containing the compounds as the active ingredient
12/07/2005EP1601657A1 Pyrazole modulators of atp-binding cassette transporters
12/07/2005EP1353904B1 1-aryl-or 1-alkylsulfonylbenzazole derivatives as 5-hydroxytryptamine-6 ligands
12/07/2005EP1199306B1 Biarylurea derivatives
12/07/2005CN1705668A Heterocyclocarboxamide derivatives
12/07/2005CN1230421C Amide compounds and medicinal use thereof
12/07/2005CN1230166C Gyrase inhibitors and uses thereof
12/07/2005CN1230165C Azolylcarbynol derivatives of aryl (or heteroaryl) for treatment of respiratory diseases
12/06/2005US6972299 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles
12/06/2005US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
12/06/2005US6972283 Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
12/01/2005WO2005113534A2 Cxcr1 and cxcr2 chemokine antagonists
12/01/2005WO2005113527A1 Tetrahydronaphthyl- piperazines as 5-ht1b antagonists, inverse agonists and partial agonists
12/01/2005WO2005113522A1 Azole carboxamide inhibitors of bacterial type iii protein secretion systems
12/01/2005WO2005113511A1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
12/01/2005US20050267190 Solid-state form of celecoxib having enhanced bioavailability
12/01/2005US20050267184 3-Aminocarbonyl substituted benzoylpyrazolones
12/01/2005US20050267182 Urea derivatives as FLT-3 modulators
12/01/2005US20050267163 Vanilloid receptor ligands and their use in treatments
12/01/2005US20050267123 6-Membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
12/01/2005US20050267119 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
12/01/2005US20050267118 Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade
12/01/2005US20050267098 Modulators of cellular adhesion
12/01/2005CA2567352A1 5-anilino-4-heteroarylpyrazole derivatives useful for the treatment of diabetes
12/01/2005CA2566934A1 Tetrahydronaphthyl- piperazines as 5-ht1b antagonists, inverse agonists and partial agonists
12/01/2005CA2565519A1 Cxcr1 and cxcr2 chemokine antagonists
11/2005
11/30/2005EP1600442A1 Heteroarylcarbamoylbenzene derivative
11/30/2005EP1599451A1 Pesticidal 1-ayl-3-amidoxime-pyrazole derivatives
11/30/2005EP1511385B1 Insecticidal amides with nitrogen-containing benzo-fused bicyclic ring systems
11/30/2005EP1483246B1 5-substituted-alkylaminopyrazole derivatives as pesticides
11/30/2005EP1091943B1 Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
11/30/2005CN1703397A Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists
11/30/2005CN1703395A Aryl and heteroaryl compounds and methods to modulate coagulation
11/30/2005CN1229330C N-arylating method using amino-acid as additives
11/30/2005CN1229323C Dialkoyl-halogen phenyl substituted keto-enol
11/29/2005US6969715 6-membered heterocyclic compounds useful for selective inhibition of the coagulation cascade
11/29/2005US6969713 Piperidine and piperazine acetamide derivatives
11/29/2005CA2306004C Process for preparing an aromatic compound substituted by a tertiary nitrile
11/24/2005WO2005110995A1 Cationic dyes and dyestuff for keratin fibres, containing said compounds
11/24/2005WO2005110994A2 Substituted pyrazolyl urea derivatives useful in the treatment of cancer
11/24/2005WO2005110992A1 Amido compounds and their use as pharmaceuticals
11/24/2005WO2005110971A1 Heteroaryl substituted cyclohexyl-1,4-diamine derivatives
11/24/2005WO2005092011A3 Mitotic kinesin inhibitors
11/24/2005WO2005090296A3 N-substituted benzene sulfonamides
11/24/2005US20050261353 Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
11/24/2005US20050261339 Jun N-terminal kinase inhibitors; neurodegenerative diseases; Alzheimer's disease; amyotrophic lateral sclerosis; multiple sclerosis; spinocerebellar ataxia
11/24/2005US20050261318 Protein kinase inhibitors
11/24/2005US20050261315 tyrosine kinase inhibitors such as N-(3-tert-butylisoxazol-5-yl)-2-(4-(benzyloxy)phenyl)acetamide, used for treating and preventing conditions and diseases, such as cancer, hematologic malignancies, cardiovascular disease, inflammation or multiple sclerosis
11/24/2005US20050261305 Cyclic protein tyrosine kinase inhibitors
11/24/2005US20050261293 Compounds which inhibit leukocyte adhesion mediated by VLA-4
11/24/2005US20050261276 Novel sulphones for inhibition of gamma secretase
11/24/2005US20050261273 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors
11/24/2005US20050261206 chemical intermediates to derivatives such as 3-(beta -D-Glucopyranosyloxy)-4-[(4-isopropoxyphenyl)methyl]-1-isopropyl-5-methylpyrazole; treatment of diabetes or obesity; inhibit SGLT2 (Na+/glucose cotransporter 2)
11/24/2005US20050261205 Glucopyranosyloxypyrazole derivatives, medicinal compositions containing the same and intermediates in the production thereof
11/24/2005DE4340725B4 UV-Absorber UV absorber
11/24/2005CA2566212A1 Heteroaryl-substituted cyclohexyl-1,4-diamine derivatives
11/24/2005CA2565238A1 Amido compounds and their use as pharmaceuticals
11/24/2005CA2564325A1 Substituted pyrazolyl urea derivatives useful in the treatment of cancer
11/24/2005CA2564158A1 Cationic dyes and dyestuff for keratin fibres containing said compounds
11/24/2005CA2507710A1 Tricyclic pyrazole derivatives and their use as cb1 or cb2 modulators
11/23/2005EP1597248A2 Sulfonamide derivatives as ppar modulators
11/23/2005EP1597235A1 Non-nucleoside reverse transcriptase inhibitors
11/23/2005EP1597234A2 Novel compounds
11/23/2005EP1372645B1 Reconstitutable parenteral composition containing a cox-2 inhibitor
11/23/2005EP1147090B1 Novel cationic oxidation bases, their use for dyeing keratin fibres, dyeing compositions and dyeing methods
11/23/2005EP1104406B1 Method for preparing 1-alkyl-pyrazol-5-carboxylic acid esters iii
11/23/2005EP0811007B1 Pyrazol-4-yl-benzoyl derivatives and their use as herbicides
11/23/2005EP0802906B1 Process for producing 3,5-diaryl pyrazolene
11/23/2005CN1699348A N-piperidino-1-(2,4-dichlorophenyl)-4-methyl-5-(4-chlorophenyl)pyrazole-3-formamide organic salts and their pharmaceutical compositions
11/23/2005CN1699347A Substituted pyrazolyl benzenesulfonamides for the treatment of inflamation
11/23/2005CN1698602A Usage of pyrazoline derivant in the drug preparation for preventing and/or treating cell breeding disease
11/23/2005CN1228329C 1,3-aryl substituted pyrazole having ester radical at position 5 and its liquid phase synthesis method
11/23/2005CN1228328C Pesticide intermediate compound